Eric Ende
Président chez MATINAS BIOPHARMA HOLDINGS, INC.
Fortune : 6 M $ au 30/04/2024
Postes actifs de Eric Ende
Sociétés | Poste | Début | Fin |
---|---|---|---|
MATINAS BIOPHARMA HOLDINGS, INC. | Independent Dir/Board Member | 03/04/2017 | - |
Président | 01/10/2022 | - | |
Directeur/Membre du Conseil | 03/04/2017 | 01/10/2022 | |
AVADEL PHARMACEUTICALS PLC | Directeur/Membre du Conseil | 01/12/2018 | - |
Independent Dir/Board Member | 01/12/2018 | - | |
Ende Consulting Group, Inc. | President | 07/03/2011 | - |
Mesa Therapeutics, Inc. | Directeur/Membre du Conseil | - | - |
Wellfit Holdings LLC
Wellfit Holdings LLC Information Technology ServicesTechnology Services Wellfit Holdings LLC provides computer programming services. The private company is based in Palm Beach Gardens, FL. The company was founded by Eric J. Ende. Eric J. Ende has been the CEO since incorporation. | Directeur Général | - | - |
Directeur Financier/CFO | - | - | |
Fondateur | - | - | |
Ende Biomedical Consulting Group, Inc.
Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Ende Biomedical Consulting Group, Inc. provides biomedical consulting services. The private company is based in Palm Beach Gardens. | President | 01/01/2009 | - |
Matinas BioPharma, Inc. | Directeur/Membre du Conseil | 01/05/2017 | - |
Historique de carrière de Eric Ende
Anciens postes connus de Eric Ende
Sociétés | Poste | Début | Fin |
---|---|---|---|
NEUBASE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/01/2022 | 12/05/2023 |
PROGENICS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/11/2019 | 19/06/2020 |
░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░ ░ ░░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Formation de Eric Ende
New York University | Masters Business Admin |
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Emory University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Statistiques
Internationale
Etats-Unis | 16 |
Irlande | 2 |
Opérationnelle
Director/Board Member | 8 |
President | 2 |
Masters Business Admin | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 5 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
AVADEL PHARMACEUTICALS PLC | Health Technology |
NEUBASE THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/
Merrill Lynch, Pierce, Fenner & Smith, Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch, Pierce, Fenner & Smith, Inc. (MLPFS) is the SEC-registered broker/dealer subsidiary of Merrill Lynch & Co., Inc., ultimately held by Charlotte-based Bank of America Corp. (NYSE: BAC). The firm was founded in 1958 and is headquartered in New York City. In 2010, Banc of America Securities LLC merged with MLPFS and the firm uses the trade name Bank of America Merrill Lynch. MLPFS's global strategy and economics team serves institutional and individual investors using a wide range of macroeconomic disciplines. Their analysis of global issues provides clients with investment ideas, market forecasts, macro overviews and specific sector recommendations across asset classes, regions and disciplines. Their equity research team conducts fundamental analysis on companies globally and provides institutional and retail clients with industry-specific and in-depth research and analysis on numerous industries. The firm's global fixed-income and equity-linked research focuses on fixed-income and equity derivatives, fixed-income strategy, convertibles, commodities, high-yield, mortgages, municipals and global foreign exchange. | Finance |
Ende Consulting Group, Inc. | |
Mesa Therapeutics, Inc. | |
Wellfit Holdings LLC
Wellfit Holdings LLC Information Technology ServicesTechnology Services Wellfit Holdings LLC provides computer programming services. The private company is based in Palm Beach Gardens, FL. The company was founded by Eric J. Ende. Eric J. Ende has been the CEO since incorporation. | Technology Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Ende Biomedical Consulting Group, Inc.
Ende Biomedical Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Ende Biomedical Consulting Group, Inc. provides biomedical consulting services. The private company is based in Palm Beach Gardens. | Commercial Services |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Matinas BioPharma, Inc. | |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |